‹ All Posts
DEEPAK PAL

8th Jan · SEBI-Registered Analyst

"MaxHealth: Precision Care, Exponential Growth – Empowering India's Health Future"

Technical Analysis: Current price ~₹1027.70 (Jan 8 close, -0.68% but intraday recovery from ₹1024 low), down 22% from ATH ₹1314; below 50DMA ₹1083, 100DMA ₹1095, 200DMA ₹1074 signaling bearish short-term trend. RSI(14) 48 (neutral), STOCH 30 (oversold sell), MACD -2.12 (sell), CCI -100 (sell); oscillators neutral (5 neutral/3 sell), MAs mixed (5 buy/7 sell), overall neutral rating with ATR 10.47 low volatility. Key levels: Pivot ₹1073, Support S1 ₹1070/S2 ₹1066/S3 ₹1064, Resistance R1 ₹1076/R2 ₹1080/R3 ₹1082; volume 10.6L shares (avg 12.7L), beta 0.92 suggests outperformance potential on breakout.

MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH
Downfall & Today's Upside Reasons: Lagataar downfall Sep-Dec 2025 from MA breakdowns, put-heavy OI (bearish), delivery drop (-31%), sector rotation, downside targets ₹940 amid high P/E critique. Aaj positive move (intraday +0.3% bounce) from oversold STOCH/RSI, short-covering near S3 ₹1064, VWAP ₹1028 buying; no news but 7-day +5% momentum resumption.
MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH
Upcoming Events & Impact: Q3FY26 results (late Jan 2026): Consensus rev ₹2620 Cr (+18%), PAT ₹378 Cr (+20%); beat on occupancy/ARPOB lifts 10-15% rally, miss pressures to ₹950. JHL/CRL merger closure (Q1CY26), CGHS rate hike (₹200 Cr FY27 rev), Pune land FY26 phased; positive catalysts for 1000 beds, EPS accretion ~5%.
MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH
MAXHEALTH

#StockInNews#WatchOutFor#TechnicalViews#HiddenGems#EquityResearch
Daily Chart Analysis of MAXHEALTH on 08012026.pdf
1,048 likes·88 comments